Mount Sinai School of Medicine, The Tisch Cancer Institute — New York, New York

Mount Sinai School of Medicine, The Tisch Cancer Institute is a clinical research site located in New York, New York, United States 10029-6574.

Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.

Mount Sinai School of Medicine, The Tisch Cancer Institute has participated in 2 clinical trials.

Therapeutic areas: Myeloma, HPV Positive Oropharyngeal Squamous Cell Carcinoma, Oropharynx Cancer.

Sponsors: H. Lee Moffitt Cancer Center and Research Institute, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.

Sponsor Feasibility Report

Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mount Sinai School of Medicine, The Tisch Cancer Institute?

Mount Sinai School of Medicine, The Tisch Cancer Institute has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mount Sinai School of Medicine, The Tisch Cancer Institute conducted?

Mount Sinai School of Medicine, The Tisch Cancer Institute has 2 clinical trials on record. Their work covers Myeloma, HPV Positive Oropharyngeal Squamous Cell Carcinoma, Oropharynx Cancer.

Is Mount Sinai School of Medicine, The Tisch Cancer Institute accredited by Crixeo Health?

Mount Sinai School of Medicine, The Tisch Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mount Sinai School of Medicine, The Tisch Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.